Adaptive Bio Ownership | Who Owns Adaptive Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Adaptive Bio Ownership Summary

Adaptive Bio is owned by 101.95% institutional investors, 1.93% insiders. Viking global investors lp is the largest institutional shareholder, holding 20.57% of ADPT shares. ARK Genomic Revolution is the top mutual fund, with 7.81% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adaptive Bio	101.95%	1.93%	-3.87%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Viking global investors lp	29.99M	20.57%	$108.58M
Rubric capital management lp	14.00M	9.60%	$50.68M
Blackrock	11.66M	8.00%	$42.22M
Matrix capital management company, lp	11.57M	7.94%	$41.89M
Ark investment management	11.41M	7.83%	$41.31M
Vanguard group	10.23M	7.01%	$37.02M
Millennium management	9.26M	6.35%	$33.53M
Nikko asset management americas	6.92M	4.75%	$24.98M
Sumitomo mitsui trust	6.90M	4.73%	$24.98M
Massachusetts financial services co /ma/	3.91M	2.68%	$14.16M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rubric capital management lp	14.00M	1.33%	$50.68M
Pier capital	1.06M	0.57%	$3.82M
Soleus capital management	1.72M	0.55%	$6.23M
Essex investment management	623.83K	0.42%	$2.26M
Viking global investors lp	29.99M	0.42%	$108.58M
Ark investment management	11.41M	0.37%	$41.31M
Aristotle atlantic partners	2.97M	0.35%	$10.77M
Ddd partners	770.00K	0.32%	$2.79M
Matrix capital management company, lp	11.57M	0.32%	$41.89M
Nikko asset management americas	6.92M	0.29%	$24.98M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	9.26M	0.02%	8.43M
Rubric capital management lp	14.00M	1.33%	3.50M
Soleus capital management	1.72M	0.55%	1.72M
Massachusetts financial services co /ma/	3.91M	0.00%	1.32M
Jane street group	1.02M	0.00%	923.85K

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	10.23M	0.00%	-2.64M
Pictet asset management sa	1.68M	0.01%	-1.82M
Blue water life science advisors, lp	-	-	-1.69M
Braidwell lp	-	-	-1.36M
Gilder gagnon howe	-	-	-1.25M

New Positions

Holder	Shares	% Assets	Change	Value
Soleus capital management	1.72M	0.55%	1.72M	$6.23M
Corebridge financial	62.31K	0.00%	62.31K	$225.57K
Mirae asset global etfs	56.95K	0.00%	56.95K	$206.14K
Canada pension plan investment board	27.20K	0.00%	27.20K	$98.46K
Vanguard personalized indexing management	22.32K	0.00%	22.32K	$80.82K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-24.00
Mather group, llc.	-30.00
Assetmark	-80.00
Avion wealth	-139.00
Banque cantonale vaudoise	-300.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	174	-8.90%	148,628,414	4.35%	101	1.07%	91	5.81%	45	-31.82%
Mar 31, 2024	191	-4.50%	142,434,185	-0.71%	97	0.99%	86	-11.34%	66	-7.04%
Dec 31, 2023	200	5.26%	143,448,198	2.15%	99	1.05%	97	27.63%	71	-2.74%
Sep 30, 2023	190	-10.38%	140,422,154	2.47%	97	1.08%	76	-5.00%	73	-7.59%
Jun 30, 2023	212	-7.42%	137,039,956	2.52%	94	1.09%	80	-28.57%	79	25.40%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Genomic Revolution	11.52M	7.81%	243.77K
ARK Genomic Revolution ETF	11.50M	7.80%	55.34K
Nikko AM ARK Pstv Chg Innovt P JPY Acc	5.93M	4.02%	-72.07K
Vanguard Total Stock Mkt Idx Inv	4.20M	2.85%	6.60K
iShares Russell 2000 ETF	2.99M	2.03%	-6.73K
Nikko Gbl All Biological Genome Eq MF	2.06M	1.40%	-121.82K
Vanguard Institutional Extnd Mkt Idx Tr	1.77M	1.20%	-14.78K
Vanguard Small Cap Index	1.76M	1.19%	3.45K
Pictet Biopharmaceutical Mother	1.74M	1.18%	192.51K
MFS New Discovery I	1.68M	1.14%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 18, 2024	PISKEL KYLE	Chief Financial Officer	Sell	$1.24K
Aug 22, 2024	Taylor Stacy L	SVP and General Counsel	Sell	$121.08K
Mar 05, 2024	PISKEL KYLE	Principal Accounting Officer	Sell	$26.50K
Mar 05, 2024	Taylor Stacy L	SVP and General Counsel	Sell	$22.73K
Mar 05, 2024	Taylor Stacy L	SVP and General Counsel	Sell	$23.23K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	1
2024 Q2	-	-
2024 Q1	-	14
2023 Q4	-	1

ADPT Ownership FAQ

Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 101.95%, followed by 1.93% insiders and -3.88% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 44.97%, which Adaptive Bio exceeds.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 20.57%), Rubric capital management lp (14M shares, 9.60%), and Blackrock (11.66M shares, 8.00%). Together, they hold 38.18% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

Yes, BlackRock owns 8.00% of Adaptive Bio, totaling 11.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.22M$. In the last quarter, BlackRock increased its holdings by 473.88K shares, a 4.23% change.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Rubric capital management lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 1.33% of its assets in 14M Adaptive Bio shares, valued at 50.68M$.

Who is the top mutual fund holder of Adaptive Bio shares?

ARK Genomic Revolution is the top mutual fund holder of Adaptive Bio shares, with 7.81% of its total shares outstanding invested in 11.52M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools